Untreated
Clinical trials for Untreated explained in plain language.
Never miss a new study
Get alerted when new Untreated trials appear
Sign up with your email to follow new studies for Untreated, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug delay the need for lymphoma treatment?
Disease control Not yet recruitingThis phase 2 trial compares two approaches for people with untreated, low-tumor-burden follicular lymphoma: receiving the investigational drug epcoritamab or being closely monitored without treatment. The goal is to see if epcoritamab can extend the time before standard treatment…
Matched conditions: UNTREATED
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New hope for pancreatic cancer: combo therapy enters phase 2 trial
Disease control Not yet recruitingThis study tests a new treatment for people with advanced pancreatic cancer that has not been treated before. It combines a hedgehog inhibitor (NLM-001) with standard chemotherapy and two immunotherapy drugs. The goal is to see if this combination shrinks tumors better than chemo…
Matched conditions: UNTREATED
Phase 2 • Sponsor: Nelum Corp • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC